(Allergan plc)

	AGN latest price $168.4732 (-1.15%) ($167.8207 - $171.0051) on Thu. Nov. 9, 2017.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.74% (three month average)
RSI	30
Latest Price	$168.4732(-1.15%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN declines -0.3% a day on average for past five trading days.
Weekly Trend	AGN declines -2.5% a week on average for past two weeks.
Market Behavior	Broad based sell-off for large cap. Broad based sell-off for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(50%)    XLV(49%)    SPY(45%)    VT(45%)    XBI(45%)
Factors Impacting AGN price	AGN will decline at least -0.87% in a week (0% probabilities).   VIXM(-30%)    TLT(-19%)    UUP(-17%)    GDXJ(-5%)    SHY(-4%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.87% (StdDev 1.74%)
Hourly BBV	0 ()
Intraday Trend	-0.6%

1 - 5 Day Possible Target	$163.39(-3.02%)
Resistance Level	$177.64
5 Day Moving Average	$169.49(-0.6%)
10 Day Moving Average	$171.73(-1.9%)
20 Day Moving Average	$177.64(-5.16%)
To recent high	-27.1%
To recent low	0%
Market Cap	$55.546b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed